Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women.

Singh DK, Anastos K, Hoover DR, Burk RD, Shi Q, Ngendahayo L, Mutimura E, Cajigas A, Bigirimani V, Cai X, Rwamwejo J, Vuolo M, Cohen M, Castle PE.

J Infect Dis. 2009 Jun 15;199(12):1851-61. doi: 10.1086/599123.

2.

Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).

Kojic EM, Cu-Uvin S, Conley L, Bush T, Onyekwuluje J, Swan DC, Unger ER, Henry K, Hammer JH, Overton ET, Darragh TM, Palefsky JM, Vellozzi C, Patel P, Brooks JT.

Sex Transm Dis. 2011 Apr;38(4):253-9. doi: 10.1097/OLQ.0b013e3181f70253.

PMID:
20966828
3.

Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.

Anastos K, Hoover DR, Burk RD, Cajigas A, Shi Q, Singh DK, Cohen MH, Mutimura E, Sturgis C, Banzhaf WC, Castle PE.

PLoS One. 2010 Oct 20;5(10):e13525. doi: 10.1371/journal.pone.0013525.

4.

High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding.

Theiler RN, Farr SL, Karon JM, Paramsothy P, Viscidi R, Duerr A, Cu-Uvin S, Sobel J, Shah K, Klein RS, Jamieson DJ.

Obstet Gynecol. 2010 Jun;115(6):1150-8. doi: 10.1097/AOG.0b013e3181e00927.

PMID:
20502284
5.

Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection.

Yamada R, Sasagawa T, Kirumbi LW, Kingoro A, Karanja DK, Kiptoo M, Nakitare GW, Ichimura H, Inoue M.

J Med Virol. 2008 May;80(5):847-55. doi: 10.1002/jmv.21170.

PMID:
18360898
6.

Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.

Heard I, Poizot-Martin I, Potard V, Etienney I, Crenn-Hebert C, Moore C, Touraine P, Cubie H, Costagliola D; ANRS-C017 VIHGY Study Group.

J Infect Dis. 2016 May 1;213(9):1455-61. doi: 10.1093/infdis/jiv751. Epub 2015 Dec 21.

PMID:
26690345
7.

Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.

Hanisch RA, Sow PS, Toure M, Dem A, Dembele B, Toure P, Winer RL, Hughes JP, Gottlieb GS, Feng Q, Kiviat NB, Hawes SE; University of Washington-Dakar HIV and Cervical Cancer Study Group.

J Clin Virol. 2013 Dec;58(4):696-702. doi: 10.1016/j.jcv.2013.10.012. Epub 2013 Oct 18.

8.

Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.

Keller MJ, Burk RD, Xie X, Anastos K, Massad LS, Minkoff H, Xue X, D'Souza G, Watts DH, Levine AM, Castle PE, Colie C, Palefsky JM, Strickler HD.

JAMA. 2012 Jul 25;308(4):362-9. doi: 10.1001/jama.2012.5664.

9.

Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.

Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM.

J Infect Dis. 2001 Feb 1;183(3):383-91. Epub 2000 Dec 29.

PMID:
11133369
10.

Infection with human papillomavirus and HIV among young women in Kampala, Uganda.

Banura C, Franceschi S, Doorn LJ, Arslan A, Wabwire-Mangen F, Mbidde EK, Quint W, Weiderpass E.

J Infect Dis. 2008 Feb 15;197(4):555-62. doi: 10.1086/526792.

PMID:
18237268
11.

Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa.

Marais DJ, Passmore JA, Denny L, Sampson C, Allan BR, Williamson AL.

J Med Virol. 2008 Jun;80(6):953-9. doi: 10.1002/jmv.21166.

PMID:
18428143
12.

Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men.

Parisi SG, Cruciani M, Scaggiante R, Boldrin C, Andreis S, Dal Bello F, Pagni S, Barelli A, Sattin A, Mengoli C, Palù G.

BMC Infect Dis. 2011 May 25;11:150. doi: 10.1186/1471-2334-11-150.

13.

Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia.

Camargo M, Soto-De Leon SC, Munoz M, Sanchez R, Peña-Herrera D, Pineda-Peña AC, Sussmann O, Paez C, Perez-Prados A, Patarroyo ME, Patarroyo MA.

BMC Cancer. 2014 Jun 18;14:451. doi: 10.1186/1471-2407-14-451.

14.

Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.

ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H, Mhina M, Kashaija P, Ockert S, Yu X, et al.

Int J Cancer. 1992 Jun 19;51(4):515-21.

PMID:
1318265
15.

Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.

Darwich L, Cañadas MP, Sirera G, Alameda F, Forcada P, Delas J, Fernández I, Llatjós M, Coll J, Clotet B, Videla S.

Int J Gynecol Cancer. 2011 Nov;21(8):1486-90. doi: 10.1097/IGC.0b013e31822a0195.

PMID:
21892092
16.

Epidemiologic risk profile of human papillomavirus infections in human immunodeficiency virus-positive Chinese women.

Zhang YX, Xiong Y, Gui XE, Chen SH, Rong YP, Cai HB.

Jpn J Infect Dis. 2011;64(5):411-6.

17.

Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.

Moodley JR, Constant D, Hoffman M, Salimo A, Allan B, Rybicki E, Hitzeroth I, Williamson AL.

BMC Cancer. 2009 Aug 7;9:275. doi: 10.1186/1471-2407-9-275.

18.

Human papillomavirus type-specific risk of cervical cancer in a population with high human immunodeficiency virus prevalence: case-control study.

Naucler P, Mabota da Costa F, da Costa JL, Ljungberg O, Bugalho A, Dillner J.

J Gen Virol. 2011 Dec;92(Pt 12):2784-91. doi: 10.1099/vir.0.034298-0. Epub 2011 Sep 7.

PMID:
21900420
19.

Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.

Hankins C, Coutlée F, Lapointe N, Simard P, Tran T, Samson J, Hum L.

CMAJ. 1999 Jan 26;160(2):185-91.

20.

Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.

Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM.

Arch Pediatr Adolesc Med. 2000 Feb;154(2):127-34.

PMID:
10665598

Supplemental Content

Support Center